The
report “ Partnerships, Licensing, Investments and M&A Deals and
Trends for February 2016 in Pharmaceuticals ”, has been prepared
based on an in-depth market analysis with inputs from industry
experts.
GlobalData's
Partnerships,
Licensing, Investments and M&A Deals and Trends for February 2016
in
Pharmaceuticals report is an essential source of data and trend
analysis on partnerships, licensing, mergers and acquisitions (M&As)
and financings in the pharmaceuticals industry. The report provides
detailed information on partnership and licensing transactions, M&As,
equity/debt offerings, private equity, and venture financing
registered in the pharmaceuticals industry in February 2016. The
report portrays detailed comparative data on the number of deals and
their value in the last six months, subdivided by deal types, various
therapy areas, and geographies. Additionally, the report provides
information on the top financial advisory firms in the
pharmaceuticals industry.
Data
presented in this report is derived from GlobalDatas proprietary
in-house Pharmaceuticals eTrack deals database and primary and
secondary research.
Download
Sample copy of this Report @
Scope
-
Analysis of the market trends for the pharmaceutical industry in the
global arena.
-
Review of deal trends in the cardiovascular, central nervous system,
dermatology, ear nose throat disorders, gastrointestinal, genito
urinary system and sex hormones, hematological disorders, hormonal
disorders, immunology, infectious disease, male health, metabolic
disorders, mouth and dental disorders, musculoskeletal, oncology,
ophthalmology, respiratory, toxicology, and women's health segments.
-
Analysis of partnerships, licensing, M&As, equity/debt offerings,
private equity, and venture financing deals in the pharmaceutical
industry.
-
Analysis of therapy areas which are very active in terms of venture
capital financing, partnerships, licensing agreements, equity/debt
offerings, and M&As.
-
Analysis of deals based on different payment modes, including upfront
and milestone payments, primarily in partnerships and licensing
agreements in the pharmaceutical industry.
-
Analysis of partnership and licensing deals based on clinical stage
of development of products.
-
Summary of the pharmaceutical deals globally in the six months.
-
Information on the top deals happened in the pharmaceutical industry.
-
Geographies covered include - North America, Europe, Asia Pacific,
South & Central America, and the Middle East & Africa.
-
League tables of financial advisors in M&As and equity/debt
offerings. This includes key advisors such as Morgan Stanley, Credit
Suisse, and Goldman Sachs.
Reasons
to buy
-
Enhance your decision making capability in a more rapid and time
sensitive manner.
-
Find out the major deal performing segments for investments in your
industry.
-
Evaluate the types of companies which are entering into partnership
or licensing agreements; divesting and acquiring assets.
-
Identify companies that are aggressively looking to raise capital in
the market
-
Evaluate niche therapy areas that are receiving majority of the
upfront and milestone payments in the pharmaceutical industry.
-
Identify the key venture capitalists, who are financing the
pharmaceutical and biotech companies.
-
Evaluate the clinical development stages where majority of the
partnerships and licensing agreements are happening.
-
Do deals with an understanding of how competitors are financed, and
the mergers and partnerships that have shaped the pharmaceutical
industry.
-
Identify growth segments and opportunities in each region within the
industry.
-
Look for key financial advisors where you are planning to raise
capital from the market or for acquisitions within the industry.
Browse All reports Of this
Category: http://www.marketresearchreports.biz/category/38
Table
of Content :
1
Table of Contents 2
1.1
List of Tables 6
1.2
List of Figures 9
2
Pharmaceuticals & Healthcare, Global, Deal Summary 12
2.1
Pharmaceuticals & Healthcare, Global, Deal Analysis, February
2016 12
2.2
Pharmaceuticals & Healthcare, Global, Major Deals, February 2016
14
2.2.1
Mylan to Acquire Meda for USD9.9 Billion 14
2.2.2
GTCR to Form Joint Venture with Ed Fiorentino 16
2.2.3
Baxalta Enters into Agreement with Precision Biosciences 16
2.2.4
McKesson to Acquire Vantage Oncology and Biologics for USD1.2 Billion
17
2.2.5
Ipsen Enters into Licensing Agreement with Exelixis 17
2.3
Pharmaceuticals & Healthcare, Global, by Type, Number of Deals,
February 2016 19
2.4
Pharmaceuticals & Healthcare, Global, by Type, Deal Values,
February 2016 20
3
Pharmaceuticals and Healthcare, Global, Deals, Summary, by Type 21
3.1
Pharmaceuticals & Healthcare, Global, M&A, February 2016 21
3.1.1
Top M&A Deals in February 2016 22
3.1.2
Pharmaceuticals & Healthcare, Global, M&A Deals by Therapy
Area, September 2015 - February 2016 23
3.2
Pharmaceuticals & Healthcare, Global, Equity Offering Deals,
February 2016 25
3.2.1
Top Equity Offering Deals in February 2016 26
3.2.2
Pharmaceuticals & Healthcare, Global, Equity Offering Deals by
Therapy Area, September 2015 - February 2016 27
3.3
Pharmaceuticals & Healthcare, Global, Private Equity and Venture
Capital Deals, February 2016 29
3.3.1
Top PE/VC Deals in February 2016 30
3.3.2
Pharmaceuticals & Healthcare, Global, PE/VC by Therapy Area,
February 2016 31
3.3.3
Pharmaceuticals & Healthcare, Global, Venture Capital Deals by
Stage of Financing, February 2016 33
3.3.4
Pharmaceuticals & Healthcare, Global, Top Venture Financing
Firms, September 2015-February 2016 35
3.3.5
Pharmaceuticals & Healthcare, Global, Top VC Backed Companies,
September 2015-February 2016 36
4
Pharmaceuticals & Healthcare, Global, Partnership Deals, February
2016 37
4.1
Pharmaceuticals & Healthcare, Global, Partnership Deals, February
2016 37
4.2
Pharmaceuticals & Healthcare, Global, Partnership Deals by
Therapy Area, September 2015 - February 2016 39
4.3
Pharmaceuticals & Healthcare, Global, Partnership Deals by
Upfront and Milestone Payments and Deal Values (US$ m), February 2016
41
4.3.1
Pharmaceuticals & Healthcare, Global, Top Partnership Deals by
Payment Mode, February 2016 42
4.4
Pharmaceuticals & Healthcare, Global, Partnership Deals by
Therapy Area, by Upfront and Milestone Payments and Deal Values (US$
m), September 2015 - February 2016 43
4.5
Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase,
Number Of Deals, September 2015 - February 2016 45
4.6
Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase,
Deal Values (US$ m), September 2015 - February 2016 46
About
us
MarketResearchReports.biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact
us:
Mr.
Nachiket
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-618-1030
USA:
Canada Toll Free: 866-997-4948
No comments:
Post a Comment